Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
Next EPS Date | 5/1/24 | EPS Growth Rate | +30.0% |
---|---|---|---|
Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +1.6% |
Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/10 | Q310 | $1.30 | $1.27 | +$0.03 | N/A | N/A | N/A | Details | |||
2/8/11 | Q410 | $1.25 | $1.28 | -$0.03 | $4.42B | $4.64B | N/A | Details | |||
5/11/11 | Q111 | $1.04 | $1.04 | $0.00 | $4.08B | $4.25B | N/A | Details | |||
7/27/11 | Q211 | $1.10 | $1.09 | +$0.01 | $4.21B | $4.24B | N/A | Details | |||
11/2/11 | Q311 | $1.25 | $1.23 | +$0.02 | $4.34B | $4.54B | N/A | Details | |||
2/15/12 | Q411 | $1.59 | $1.58 | +$0.01 | $5.68B | $5.61B | = | Details | |||
5/9/12 | Q112 | $1.47 | $1.44 | +$0.03 | $5.1B | $5.51B | = | Details | |||
8/2/12 | Q212 | $1.28 | $1.28 | $0.00 | $5B | $5.08B | = | Details |